Livzon Pharmaceutical : was recognized as the National Enterprise Technology Center with High Scores

Recently, the General Office of National Development and Reform Commission announced the evaluation result of the National Enterprise Technology Centers in 2021, and 72 enterprise technology centers was scored higher than 90 and granted Excellence. Livzon Pharmaceutical Group successfully passed the evaluation with a high score of 90.3.

The national enterprise technology center refers to an enterprise technology center with strong technological innovation capability, leading research and development as well as innovation level in the industry, core technology with independent intellectual property rights, and international competitiveness recognized by the National Development and Reform Commission. The qualifications are jointly awarded by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs, and the State Administration of Taxation. Its accreditation review process is strict, and the evaluation results are authoritative. It is currently one of the highest-standard and most influential technological innovation platforms in China.

Livzon Pharmaceutical Group is always insisting on R&D and innovation, and has state R&D platforms including "National Engineering and Research Center for Modernization of Traditional Chinese Medicine, National and Local Joint Engineering Research Center for Continuous Release Microsphere Technology" and 8 provincial R&Dplatform including "Guangdong Provincial Engineering Technology Research and Development Center for Digital Chinese Medicine, Guangdong Province Livzon Pharmaceutical Key Engineering Technology Research and Development Center, Guangdong Province Livzon In Vitro Diagnostic Engineering Technology Research and Development Center, Guangdong Province CephalosporinsEngineering Technology Research Center, and Guangdong Fermented Pharmaceutical Engineering Technology Research and Development Center,etc. The Shenqi Fuzheng Injection and Ilaprazole have successively won the First Prize of Guangdong Province Science and Technology Progress Award and the Second Prize of National Science and Technology Progress Award.

Livzon Pharmaceutical Group has been recognized as the national enterprise technology center since 2009. The evaluation with excellence this time is a high affirmation and recognition to Livzon Pharmaceutical Group and is also a comprehensive assessment to the operation of Livzon Pharmaceutical Group in the past two years. Livzon Pharmaceutical Group will continue to develop driven by R&D and innovation and will be dedicated to making new and greater contributions to the human health.